Tilray Stock Rises in Bull Market But Long-Term Outlook Remains Risky
-
Tilray stock has fallen 83% in 5 years but is rising in the current bull market, making now seem like an good time to invest
-
Tilray is diversifying into alcohol and expects to generate free cash flow in 2024, which would be a significant catalyst
-
Issues remain with Tilray's ability to access the US cannabis market if legalization occurs due to problems with its MedMen deal
-
Tilray is not a safe stock due to industry risks outside of its control like legalization timing, pricing changes, and investor sentiment
-
The article author thinks Tilray can work out operational issues long-term and its alcohol revenue offers financial flexibility, but only investors willing to accept risk and wait 5+ years should consider buying